pmc logo imageJournal ListSearchpmc logo image
Logo of vhriskmanJournal URL: redirect3.cgi?&&auth=0VqOP_QKvefs9Wr9JKEVwRZvVhbstnz8UiLcBWA18&reftype=publisher&issue-id=177648&journal-id=391&FROM=TOC|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://dovepress.com/articles.php?journal_id=69
Other Issues:  previous | next | latest | archive
Volume 4(6);  December 2008
Reviews
Update on the use of trandolapril in the management of cardiovascular disorders
Ariel Diaz and Anique Ducharme
Vasc Health Risk Manag. 2008 December; 4(6): 1147–1158.
PMCID: PMC2663436
Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine
Menno T Pruijm, Marc P Maillard, and Michel Burnier
Vasc Health Risk Manag. 2008 December; 4(6): 1159–1166.
PMCID: PMC2663443
Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
Marc K Israel, Eva Istvan, and Michelle A Baron
Vasc Health Risk Manag. 2008 December; 4(6): 1167–1178.
PMCID: PMC2663444
Peripheral artery disease: potential role of ACE-inhibitor therapy
Giuseppe Coppola, Giuseppe Romano, Egle Corrado, Rosa Maria Grisanti, and Salvatore Novo
Vasc Health Risk Manag. 2008 December; 4(6): 1179–1187.
PMCID: PMC2663435
Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
Floris Alexander van de Laar
Vasc Health Risk Manag. 2008 December; 4(6): 1189–1195.
PMCID: PMC2663450
Safety and efficacy of cilostazol in the management of intermittent claudication
Yung-Wei Chi, Carl J Lavie, Richard V Milani, and Christopher J White
Vasc Health Risk Manag. 2008 December; 4(6): 1197–1203.
PMCID: PMC2663440
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
Kalathil K Sureshkumar
Vasc Health Risk Manag. 2008 December; 4(6): 1205–1220.
PMCID: PMC2663460
Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential
Nasser Mikhail
Vasc Health Risk Manag. 2008 December; 4(6): 1221–1227.
PMCID: PMC2663457
Cardiometabolic risk in psoriasis: differential effects of biologic agents
Mariana J Kaplan
Vasc Health Risk Manag. 2008 December; 4(6): 1229–1235.
PMCID: PMC2663453
Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
Luis M Ruilope
Vasc Health Risk Manag. 2008 December; 4(6): 1237–1248.
PMCID: PMC2663442
Long-acting nifedipine in the management of the hypertensive patient
Morgan E Snider, Donald S Nuzum, and Angie Veverka
Vasc Health Risk Manag. 2008 December; 4(6): 1249–1257.
PMCID: PMC2663456
Managing hypercholesterolemia and its correlation with carotid plaque morphology in patients undergoing carotid endarterectomy
Kittipan Rerkasem, Patrick J Gallagher, Robert F Grimble, Philip C Calder, and Clifford P Shearman
Vasc Health Risk Manag. 2008 December; 4(6): 1259–1264.
PMCID: PMC2663431
Beta-glucans in the treatment of diabetes and associated cardiovascular risks
Jiezhong Chen and Kenneth Raymond
Vasc Health Risk Manag. 2008 December; 4(6): 1265–1272.
PMCID: PMC2663451
Role of stress fibers and focal adhesions as a mediator for mechano-signal transduction in endothelial cells in situ
Kazuo Katoh, Yumiko Kano, and Shigeo Ookawara
Vasc Health Risk Manag. 2008 December; 4(6): 1273–1282.
PMCID: PMC2663434
Proinsulin C-peptide: Friend or foe in the development of diabetes-associated complications?
Lina Nordquist and M Johansson
Vasc Health Risk Manag. 2008 December; 4(6): 1283–1288.
PMCID: PMC2663462
Role of TGF-β on cardiac structural and electrical remodeling
Roberto Ramos-Mondragón, Carlos A Galindo, and Guillermo Avila
Vasc Health Risk Manag. 2008 December; 4(6): 1289–1300.
PMCID: PMC2663446
Pathophysiology of placentation abnormalities in pregnancy-induced hypertension
Mitsuko Furuya, Junji Ishida, Ichiro Aoki, and Akiyoshi Fukamizu
Vasc Health Risk Manag. 2008 December; 4(6): 1301–1313.
PMCID: PMC2663465
The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target
Jean-Jacques Mourad
Vasc Health Risk Manag. 2008 December; 4(6): 1315–1325.
PMCID: PMC2663439
Mechanisms of endothelial dysfunction in obstructive sleep apnea
Amy Atkeson and Sanja Jelic
Vasc Health Risk Manag. 2008 December; 4(6): 1327–1335.
PMCID: PMC2663447
Thrombosis in the critically ill neonate: incidence, diagnosis, and management
Alex Veldman, Marcel F Nold, and Ina Michel-Behnke
Vasc Health Risk Manag. 2008 December; 4(6): 1337–1348.
PMCID: PMC2663458
Vildagliptin: a new oral treatment for type 2 diabetes mellitus
Chantal Mathieu and Evy Degrande
Vasc Health Risk Manag. 2008 December; 4(6): 1349–1360.
PMCID: PMC2663430
Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease
Michael R Graham, Peter Evans, Bruce Davies, and Julien S Baker
Vasc Health Risk Manag. 2008 December; 4(6): 1361–1371.
PMCID: PMC2663454
Emergence of new oral antithrombotics: a critical appraisal of their clinical potential
Michael Rud Lassen and Volker Laux
Vasc Health Risk Manag. 2008 December; 4(6): 1373–1386.
PMCID: PMC2663445
Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
William H Frishman, Linda S Henderson, and Mary Ann Lukas
Vasc Health Risk Manag. 2008 December; 4(6): 1387–1400.
PMCID: PMC2663448
Rapid Communication
Dual factor pulse pressure: body mass index and outcome in type 2 diabetic subjects on maintenance hemodialysis. A longitudinal study 2003–2006
Lydia Foucan, Kheira Hue, Jocelyn Inamo, Jacqueline Deloumeaux, Anne Blanchet-Deverly, Henry Merault, and Jean-Marc Gabriel
Vasc Health Risk Manag. 2008 December; 4(6): 1401–1406.
PMCID: PMC2663455
Original Research
Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study
Toivo Laks, Ester Keba, Mariann Leiner, Eero Merilind, Mall Petersen, Sirje Reinmets, Sille Väli, Terje Sööt, and Karin Otter
Vasc Health Risk Manag. 2008 December; 4(6): 1407–1416.
PMCID: PMC2663459
The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions
Oyku Gulmez, Ilyas Atar, Bülent Ozin, Mehmet Emin Korkmaz, Asli Atar, Alp Aydinalp, Aylin Yildirir, and Haldun Muderrisoglu
Vasc Health Risk Manag. 2008 December; 4(6): 1417–1422.
PMCID: PMC2663464
Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis
Naheed Aryaeian, Farhad Shahram, Mahmoud Djalali, Mohammad R Eshragian, Abolghasem Djazayeri, Abdolfatah Sarrafnejad, Nasim Naderi, Maryam Chamari, Fariha Fatehi, and Mahnaz Zarei
Vasc Health Risk Manag. 2008 December; 4(6): 1423–1432.
PMCID: PMC2663461
Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm
Bernd Muehling, Alexander Oberhuber, Hubert Schelzig, Gisela Bischoff, Nikolaus Marx, Ludger Sunder-Plassmann, and Karl H Orend
Vasc Health Risk Manag. 2008 December; 4(6): 1433–1437.
PMCID: PMC2663432
Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia
Catalin Mindrescu, Rakesh P Gupta, Eileen V Hermance, Mary C DeVoe, Vikas R Soma, John T Coppola, and Cezar S Staniloae
Vasc Health Risk Manag. 2008 December; 4(6): 1439–1447.
PMCID: PMC2663433
Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes
Sandra Beer, François Feihl, Juan Ruiz, Irène Juhan-Vague, Marie-Françoise Aillaud, Sandrine Golay Wetzel, Lucas Liaudet, Rolf C Gaillard, and Bernard Waeber
Vasc Health Risk Manag. 2008 December; 4(6): 1449–1458.
PMCID: PMC2663449
Characterization of the vasodilatory action of testosterone in the human pulmonary circulation
Alyson M Smith, Robert T Bennett, T Hugh Jones, Mike E Cowen, Kevin S Channer, and Richard D Jones
Vasc Health Risk Manag. 2008 December; 4(6): 1459–1466.
PMCID: PMC2663441
Sleep restriction increases white blood cells, mainly neutrophil count, in young healthy men: A pilot study
Karim Zouaoui Boudjeltia, Brice Faraut, Patricia Stenuit, Maria José Esposito, Michal Dyzma, Dany Brohée, Jean Ducobu, Michel Vanhaeverbeek, and Myriam Kerkhofs
Vasc Health Risk Manag. 2008 December; 4(6): 1467–1470.
PMCID: PMC2663438
Case Reports
Association of angiitis of central nervous system, cerebral amyloid angiopathy, and Alzheimer’s disease: Report of an autopsy case
Cédric Annweiler, Marc Paccalin, Gilles Berrut, Caroline Hommet, Christian Lavigne, Jean-Paul Saint-André, and Olivier Beauchet
Vasc Health Risk Manag. 2008 December; 4(6): 1471–1474.
PMCID: PMC2663463
Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature
Kathleen Stergiopoulos, Joseph J Brennan, Robin Mathews, John F Setaro, and Smadar Kort
Vasc Health Risk Manag. 2008 December; 4(6): 1475–1480.
PMCID: PMC2663437
Corrigendum
Corrigendum
Vasc Health Risk Manag. 2008 December; 4(6): 1481.
PMCID: PMC2663452
Corrects: Corrigendum. Vasc Health Risk Manag. 2008 December; 4(6): 1481.
Other Issues:  previous | next | latest | archive